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ABSTRACT Cells of budding yeast organize their cy-
toskeleton in a highly polarized manner during vegetative
growth. Selection of a site for polarization requires a group of
proteins including a Ras-like GTPase, Bud1, and its regula-
tors. Another group of proteins, which includes a Rho-like
GTPase (Cdc42), its guanine nucleotide exchange factor
(Cdc24), and Bem1, is necessary for organization of the actin
cytoskeleton and for cell polarization. We have proposed
previously that the Bud1 protein, through its GTPase cycle,
determines the localization of one or more of the cell polarity
proteins to the bud site. Herein we demonstrate that Bud1
directly interacts with Cdc24 and Bem1: Bud1 in its GTP-
bound form associates preferentially with Cdc24, whereas the
GDP-bound form of Bud1 associates with Bem1. We also
present subcellular fractionation data for Bud1 that is con-
sistent with the idea that Bud1 can travel between the site for
budding on the plasmamembrane and the cytosol. We propose
that Bud1 can exist in two active states for association with
different partners and that the switch from Bud1–GTP to
Bud1–GDP provides a regulatory device for ordered assembly
of a macromolecular complex at the bud site.
Cells of the budding yeast Saccharomyces cerevisiae are highly
polarized during their vegetative cell cycle and during mating.
During vegetative growth, all cell surface growth takes place
in the bud, and cytoskeletal elements are oriented toward this
new bud (1, 2). The process of bud initiation is thought to
involve several distinct molecular events. (i) A specific site for
budding is selected. (ii) Assembly of components required for
bud formation takes place at the chosen site to restrict cell
growth to that position. (iii) The actin cytoskeleton is orga-
nized toward that site and secretion is targeted to it. The choice
of budding site determines the axis for cell polarity and the cell
division plane. The site chosen for polarization is dependent
upon cell type: a and a cells exhibit an axial pattern, in which
mother and daughter cells choose new bud sites adjacent to the
previous bud site. In contrast, aya cells exhibit a bipolar
pattern, in which mother and daughter cells choose new bud
sites at either end of the cell (3–5).
Three different classes of yeast genes are required for proper
bud site selection in the different cell types. BUD3, BUD4,
AXL1, andAXL2yBUD10 are required only in a and a cells and
are thought to be involved in recognizing or constituting an
axial landmark in these cells (3, 6–10). BUD6, BUD7, BUD8,
and BUD9 are required only in aya cells and are thought to be
involved in recognizing or constituting the bipolar landmarks
in this cell type (11). In contrast, BUD1, BUD2, and BUD5 are
required for bud site selection in all cell types: mutants
defective in these genes exhibit a random budding pattern in
a, a, and aya cells (3, 12–14). It has been proposed that Bud1,
Bud2, and Bud5 function as general bud site selection ma-
chinery that brings other proteins to the cell-type-specific
landmarks in a, a, and aya cells (3).
Bud1 (also known as Rsr1) has strong sequence similarity to
the Ras family of proteins (12) and is indeed aGTPase (13, 15).
Bud2 has sequence similarity to GTPase-activating proteins
and has been shown to activate GTP hydrolysis by Bud1 (13).
Bud5 has sequence similarity to the guanine nucleotide ex-
change protein Cdc25 (14, 16) and catalyzes GDP–GTP
exchange for Bud1 in vitro (17). The general bud site selection
machinery (Bud1, Bud2, and Bud5) thus makes up a functional
GTPase module, a GTPase and its regulatory proteins.
A group of genes that includes CDC42, CDC24, and BEM1
is required for organizing the actin cytoskeleton toward the
chosen site. Conditional mutants defective in these genes fail
to form a bud, instead exhibiting unpolarized cell surface
growth at nonpermissive temperature (18–23). Thus these
genes appear to be involved in polarity establishment (1, 2).
CDC42 and CDC24 encode a Rho-like GTPase and its ex-
change factor, respectively (18, 24); BEM1 encodes a protein
with two SH3 domains (22). A variety of genetic and physio-
logical observations led to the hypothesis that the Bud1
GTPase recruits proteins such as Cdc24, Cdc42, or Bem1 to
the bud site by associating with them in a guanine nucleotide-
dependent manner (3, 13).
Herein we have used an in vitro binding assay to test directly
whether Bud1 can interact with these proteins. We show that
Bud1 in its GTP-bound form associates preferentially with
Cdc24, whereas the GDP-bound form of Bud1 associates with
Bem1. We also present in vivo and in vitro analysis of a mutant
Bud1 protein altered in its presumed effector domain that
provides support for the functional relevance of some of these
in vitro interactions. We also provide biochemical evidence
suggesting that Bud1 can exist in both membrane and cytosolic
fractions. Finally, we propose a model for how the Bud1
GTPase cycle directs cell polarity during budding that accom-
modates these and other observations.
MATERIALS AND METHODS
Media, Growth Conditions, and Yeast Strains. Standard
yeast culture media were prepared essentially as described
(25). Standard procedures were used for yeast transformation
(25). Strains with the temperature-sensitive cdc24 mutation
(Y147) transformed with 2-mm plasmid (pRS425) carrying
BUD1, bud1T35A, or vector alone were streaked on SD-leu
plates containing 1 M sorbitol and incubated at 258C or 368C.
A yeast strain carrying the bud1T35A allele (HPY172) was
constructed by two-step gene replacement (26). Genotypes of
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yeast strains are the following: HPY172,MATa ura3–52 lys2–801
ade2–101 his3D200 leu2D1 trp1D63 bud1T35A; HPY22, isogenic
BUD1 strain; Y147, MATa cdc24–4 ura3 leu2–3,112 his3 (12).
Yeast strains expressing hemagglutinin (HA) epitope-
tagged Bud1, Bud1G12V, and Bud1K16N were constructed by
two-step gene replacement (26) using plasmids pHP659,
pHP660, and pHP655, respectively. Genotypes of yeast strains
are the following: HPY164–1 (Bud1-HA), MATa ura3–52
his3-D1 leu2 trp1D63 prb1-1122 pep4–3 prc1–407 BUD1-HA;
HPY166–1 (Bud1G12V-HA), isogenic to HPY164-1 except
bud1G12V-HA; HPY167 (Bud1K16N), isogenic to HPY164-1
except bud1K16N-HA.
Plasmids. To overexpress wild-type Bud1 in yeast, a SacI–
SalI fragment carrying BUD1 from pPB290 (12) was cloned
into pRS425 (2-mm LEU2), generating pHP674-1. To overex-
press Bud1T35A in yeast, a SacI–SalI fragment carrying the
bud1T35A allele from pHP656 was cloned into pRS425, gener-
ating pHP675-1.
The plasmid expressing HA-epitope-tagged Bud1 (pHP659)
was constructed by site-directed mutagenesis, resulting in
insertion of the 9-amino acid HA epitope after residue 202 of
Bud1. Plasmids pHP660 and pHP655 are identical to pHP659
except that they carry mutations affecting residue 12
(Bud1G12V) or 16 (Bud1K16N), respectively. These mutations
were introduced by substituting a SacI–ClaI fragment carrying
each mutation from YEp(rsr1val12) or YEp(rsr1asn16) (27).
To express Bud1 as a glutathione S-transferase (GST) fusion
protein inEscherichia coli, full-length Bud1 was cloned into the
vector pGEX, generating plasmid pRS4 (gift of H. Maruta,
Ludwig Institute for Cancer Research, Victoria, Australia).
GST–Bud1T35A was expressed by using plasmid pHP649, which
is the same as pRS4 except for a single amino acid substitution
at residue 35 generated by PCR. To express six-histidine-
tagged Cdc24, an NcoI–SpeI fragment was cloned into the
vector pTrcHisA (Invitrogen) to form plasmid pHP611. The
plasmid carries the coding sequence of Cdc24 from residues
153 to the end (residue 854) and thus contains the GEF
domain, the pleckstrin homology domain, and a region for
binding to Bem1 (28). To express Cdc24 as a maltose-binding
protein (MBP) fusion protein, a HincII–HincII fragment was
cloned into the vector pMAL-c (New England Biolabs). MBP–
Cdc24 carries approximately half of the coding sequence of
Cdc24, from residues 472 to 854. To express six-His-tagged
Bem1, a KpnI–KpnI fragment containing BEM1 (22) was
cloned into pTrcHisA to form pHP610. pHP610 carries the
coding sequence of Bem1 from residues 44 to 551 (the end),
which includes its two SH3 domains.
Antibodies. Cdc24-specific antibodies were raised in rabbits
(Cocalico Biologicals, Reamstown, PA) using as immunogen a
GST–Cdc24 fusion that contained amino acids 472–854 of Cdc24
and then affinity-purified on a nitrocellulose blot of MBP–Cdc24
as described in ref. 29. Bem1-specific antibodies in rabbits were
previously described in Pringle et al. (30). Monoclonal antibodies
against a HA epitope were purchased from Babco (Richmond,
CA).
Purification of Proteins.All proteins used in this study were
purified from the protease-deficient E. coli strain NB42 (gift of
Peter Jackson, Stanford University). Bud1 and Bud1T35A were
purified as GST fusion proteins as described (31). Cdc24 and
Bem1 were purified as six-histidine-tagged proteins on a
column containing iminodiacetic acid immobilized on Sepha-
rose-6B (Sigma) coupled to Co21 as described in the manu-
facturer’s protocol. MBP–Cdc24 was expressed using the
vector pMAL-c (New England Biolabs) and purified on an
amylose column essentially as described in ref. 32.
In Vitro Binding Assays. Guanine nucleotide loading of
GST–Bud1 and in vitro binding reactions were performed
essentially as described in ref. 32 with slight modifications.
Guanosine 59-[g-thio]triphosphate (GTP[gS])- and GDP-
bound GST–Bud1 were incubated for 40 min on ice with each
binding partner in 100 ml of binding buffer (20 mM TriszHCl,
pH 7.5y85 mM NaCly6 mM MgCl2y10% glyceroly0.6 mM
GDP or GTP[gS]). After incubation, glutathione-Sepharose
was added and centrifuged to collect GST–Bud1. After wash-
ing three times with 1 ml of wash buffer (10 mM TriszHCl, pH
7.6y10% glyceroly5 mM MgCl2y1 mM dithiothreitoly0.1%
Triton X-100y0.1 mM phenylmethylsulfonyl f luoride), bound
proteins were eluted from glutathione-Sepharose using elution
buffer containing 10 mM reduced glutathione and analyzed by
SDSyPAGE. Association of each binding candidate with GST–
Bud1 was detected by immunoblotting with affinity-purified
antibodies specific for each binding protein.
To determine association of Bud1 with MBP–Cdc24, the in
vitro binding reaction was performed as described above. After
incubation, amylose resin was added and centrifuged to collect
MBP–Cdc24.
Budding Pattern. The budding pattern of logarithmic-phase
cells was determined by Calcofluor staining of bud scars as
described in ref. 29. About 400 cells were analyzed for each strain.
Cell Fractionation. Cell fractionation experiments were
performed by using techniques described by Goud et al. (33)
with slight modifications. Briefly, 50 OD600 units of cells grown
at 308C were collected, washed with water, and resuspended in
0.5 ml of lysis buffer (50 mMHepes, pH 7.6y50mMKCly1mM
EGTAy1 mMMgCl2y1 mM dithiothreitoly10% glycerol) with
protease inhibitors [0.5 mM phenylmethylsulfonyl f luoridey
1:1000 dilution of a stock of aprotinin (1 mg/ml)y1:1000
dilution of a stock of leupeptin (1 mg/ml)y1:1000 dilution of a
stock of pepstatin (1 mg/ml)]. All of the following procedures
were performed at 48C. The cells were then lysed by using glass
beads in a bead beater. Cell lysates were spun at 500 3 g for
4 min, and the supernatants were subsequently centrifuged at
10,000 3 g for 10 min to produce pellet (P) and supernatant
(S) fractions. The pellets were then resuspended in the same
volume of lysis buffer as the supernatants. Aliquots of the
pellet fractions (P) were then treated with NaCl (final 500
mM), Triton X-100 (final 2%), or SDS (final 1%) before
centrifuging at 10,000 3 g again as described in ref. 34.
RESULTS
Bud1–GTP Associates with Cdc24 in Vitro. To test directly
whether Bud1 interacts with Cdc24, Bud1 was purified as a
GST fusion protein, and Cdc24 was purified as a six-
histidine-tagged protein or a MBP fusion protein from E.
coli. To test association of Bud1 and Cdc24, GST–Bud1 was
preloaded with the nonhydrolyzable GTP analogue,
GTP[gS], or with GDP and incubated with six-histidine-
tagged Cdc24. GST–Bud1 was collected with glutathione-
Sepharose beads, and the association of Cdc24 was deter-
mined by immunoblotting eluents from the beads with
antibodies specific to Cdc24. As shown in Fig. 1A, Cdc24
bound preferentially to GTP[gS]-bound Bud1 but did not to
GST. In a complementary experiment, we examined binding
of GST–Bud1 to an MBP–Cdc24 fusion protein that contains
residues 472–854 of Cdc24. MBP–Cdc24 was collected by
addition of amylose resin, and the association of Bud1 was
determined by immunoblotting using anti-GST antibodies.
GTP[gS]-bound Bud1 preferentially interacted with MBP–
Cdc24 but not with MBP (Fig. 1B). These results show that
Cdc24 interacts preferentially with GTP[gS]-bound Bud1
and that the Bud1-binding site on Cdc24 lies between
residues 472 and 854.
The Putative Effector Domain Mutant of Bud1 Bud1T35A
Does Not Bind to Cdc24. In the case of Ras, residues involved
in interacting with a target molecule, the effector, have been
defined genetically and biochemically and are localized to the
so-called effector region, which contains residues 32–40 (35).
Bud1 is identical to H-ras in this region (12). To determine
whether this region is also important for Bud1 function and
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whether Cdc24 is an effector of Bud1, we constructed a mutant
form of Bud1 with a T 3 A substitution at position 35 in the
putative effector region of Bud1. Cells with the bud1T35A
mutant allele grew normally at 16–378C, but more than 90%
of cells exhibited a random budding pattern (data not shown),
which is the same phenotype of a bud1 deletion mutant (12).
Since overproduction of Bud1 (Rsr1) can suppress a temper-
ature-sensitive cdc24 mutation (12), presumably because of
interaction between Bud1 and Cdc24, we tested whether
overexpression of bud1T35A can suppress the cdc24ts mutation.
Overexpression of bud1T35A failed to suppress the cdc24ts
mutation (Fig. 2A), suggesting that Bud1T35A was unable to
interact with Cdc24. We tested directly whether Bud1T35A can
interact with Cdc24 by purifying the mutant protein as a GST
fusion protein from E. coli. Bud1T35A was unable to interact
with Cdc24 regardless of whether it was bound to GTP[gS] or
to GDP (Fig. 2B). These results indicate that the binding of
Cdc24 to the GTP-bound form of Bud1 is functionally relevant
since their association in vitro is eliminated by the bud1T35A
mutation, which inactivates BUD1 function in vivo. These
results also indicate that the C-terminal half of Cdc24 interacts
with the effector region of Bud1.
Bud1–GDP Associates with Bem1. The Bem1 protein, like
Cdc24 and Cdc42, is important for establishment of cell polarity
and organization of actin (14, 21, 22). We tested whether Bem1
can interact with wild-type Bud1 and Bud1T35A. As shown in Fig.
3, Bem1 associated preferentially with Bud1–GDP in comparison
with GST–Bud1–GTP[gS] or with nucleotide-free GST–Bud1
(compare lane 2 with lanes 1 and 7). In contrast, Bem1 interacted
with GST–Bud1T35A preloaded with GTP[gS] or GDP with
almost equal efficiency but not with nucleotide-free GST–
Bud1T35A (Fig. 3, lanes 3, 4, and 8). Bem1 did not interact with
GST or glutathione-Sepharose (Fig. 3, lanes 5, 6, and 9). The
FIG. 1. Cdc24 binds preferentially to GTP[gS]-bound Bud1 in vitro.
(A) Association of GST–Bud1 and six-histidine-tagged Cdc24. Puri-
fied GST–Bud1 and GST (final concentration, approximately 750 nM)
were preincubated with 1 mM GDP or GTP[gS] and then incubated
with six-histidine-tagged Cdc24 (final concentration, 15 nM). Cdc24
was incubated with either GTP[gS]-bound Bud1 (lane 1) or GDP-
bound Bud1 (lane 2), or with GST that had been preincubated with
GTP[gS] (lane 3) or GDP (lane 4). Proteins bound to glutathione-
Sepharose beads were collected and analyzed by SDSyPAGE. Ap-
proximately equal amounts of GST–Bud1 and GST proteins were
recovered for each reaction as judged by Coomassie blue staining of
the gel (data not shown). Association of Cdc24 was determined by
immunoblotting with polyclonal antibodies against Cdc24. (B) Asso-
ciation of GST–Bud1 and MBP–Cdc24 in vitro. MBP–Cdc24 (750 nM)
was incubated either with GST–Bud1 (75 nM) preloaded with
GTP[gS] (lane 1) or GDP (lane 2), or with GST–Bud1 that had not
been preincubated with any nucleotides (lane 3). MBP (750 nM) was
also incubated with GST–Bud1 (75 nM) preloaded either with
GTP[gS] (lane 4) or GDP (lane 5), or with GST–Bud1 that had not
been preincubated with any nucleotides (lane 6). Proteins bound to
amylose resin were collected and analyzed by SDSyPAGE. Approxi-
mately equal amounts of MBP–Cdc24 and MBP were recovered for
each reaction as judged by Coomassie blue staining of the gel (data not
shown). Association of GST–Bud1 was determined by immunoblotting
with polyclonal antibodies against GST.
FIG. 2. Bud1 effector domain mediates interaction between Bud1
and Cdc24. (A) Overexpression of Bud1T35A fails to suppress a
temperature-sensitive cdc24 mutation. Strains with the temperature-
sensitive cdc24 mutation (Y147) transformed with 2-mm plasmid
(pRS425) carrying BUD1, bud1T35A, or vector alone were streaked on
SD-Leu plate containing 1 M sorbitol and incubated at 258C or 368C
for 3 days. (B) The Bud1T35A protein fails to interact with Cdc24 in
vitro.MBP–Cdc24 (750 nM) was incubated with wild-type GST–Bud1
(15 nM) preloaded with GTP[gS] (lane 1) or GDP (lane 2), or with
GST–Bud1T35A (15 nM) preloaded with GTP[gS] (lane 3) or GDP
(lane 4). Proteins were analyzed as in Fig. 1B. GST–Bud1T35A was
expressed by using plasmid HP649, which is the same as pRS4 (15)
except for a single amino acid substitution at residue 35.
FIG. 3. Bem1 binds preferentially to GDP-bound Bud1 in vitro.
Purified GST–Bud1, GST–Bud1T35A, and GST (approximately 750
nM) were preincubated with 1 mM GDP or GTP[gS] and then
incubated with six-histidine-tagged Bem1 (15 nM). Bem1 was incu-
bated with GTP[gS]–Bud1 (lane 1), GDP–Bud1 (lane 2), GTP[gS]–
Bud1T35A (lane 3), GDP–Bud1T35A (lane 4), GST preincubated with
GTP[gS] (lane 5), or GDP (lane 6) or with GST–Bud1 (lane 7) or
GST–Bud1T35A (lane 8) that had not been preloaded with any
nucleotides. Proteins bound to glutathione-Sepharose beads were
collected and analyzed by SDSyPAGE. Association of Bem1 was
determined by immunoblotting with polyclonal antibodies against
Bem1 (ref. 30 and Kathy Corrado and J.R.P., unpublished results). A
negative control is shown in lane 9, in which no GST–Bud1 or GST was
added.
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binding of Bud1T35A to both GTP and GDP was not noticeably
different from that of wild-type Bud1 at the concentrations tested
(data not shown). These results demonstrate that theGDP-bound
form of Bud1 specifically interacts with Bem1 and that Bud1T35A
behaves the same as the GDP-bound form of Bud1 even when
bound to GTP.
Bud1 Can Exist Both in the Membrane and Cytosolic
Fractions. We proposed previously that Bud1 brings proteins
important for polarity establishment such as Cdc24 to the bud
site on the plasma membrane. We therefore wished to know
whether Bud1 is present in both the cytosol and plasma
membrane compartments. Bud1 contains the sequence Cys-
Thr-Ile-Leu at its C terminus (12), a signal for isoprenylation
that is believed to be important for association of Bud1 with
the membrane. To determine whether Bud1 is associated with
a subcellular membrane, cell fractionation was performed by
centrifugation. Although most Bud1 ('90%) was found in the
particulate fraction that contains plasma membrane compo-
nents as well as other dense material, a significant amount of
Bud1 ('10%) was found in the soluble fraction (Fig. 4A). This
observation is consistent with the idea that Bud1 can travel
between the site for budding on the plasma membrane and the
cytosol. We further examined the nature of the interaction
between Bud1 and the particulate (presumably membranous)
fraction by treating this fraction with reagents that are known
to release peripheral or integral membrane proteins (34). Bud1
was efficiently solubilized from the particulate fractions by
treatment with 2% Triton X-100 or 1% SDS. Treatment with
0.5 M NaCl had little effect (Fig. 4A), which is similar to what
has been observed for Cdc42 (37) and Sec61 (36), an endo-
plasmic reticulum membrane protein used as a control. These
results suggest that Bud1 is tightly associated with cellular
membranes. Since GTP- or GDP-bound Bud1 interacts with
different partners, we further tested whether mutant forms of
Bud1 that are thought to be locked into GTP- or GDP-bound
forms partition differently in soluble and particulate fractions.
Interestingly, we found that Bud1G12V [analogous to constitu-
tively activated RasVal12 (27) and thus presumably in a GTP-
bound form in vivo] was present in both fractions as observed
for the wild-type protein, whereas Bud1K16N [analogous to a
dominant negative RasAsn16 (27) and thus presumably in a
GDP-bound form in vivo] was present only in the particulate
fraction (Fig. 4B). These observations suggest that Bud1–GTP
can travel between the bud site on the plasma membrane and
the cytosol but that Bud1–GDP is mainly associated with the
plasma membrane.
DISCUSSION
Bud1, Bud2, and Bud5 form a GTPase module that is required
for determining cell polarization toward certain preferred sites
in budding yeast. A key issue in understanding how these
proteins commit the yeast cell to utilize a specific site for
polarization is to identify the proteins with which the compo-
nents of this module interact. Of special interest is to identify
the proteins that interact with the GTPase Bud1. A variety of
genetic and physiological observations led to the proposal that
Bud1 might interact with proteins that are important for cell
polarity and that are thought to organize the actin cytoskeleton
(3, 13). Our studies have focused on two of these proteins,
Cdc24 and Bem1. We found that Bud1 protein binds to these
proteins in vitro and that it appears to exist in two functional
states, one GTP bound, which interacts with Cdc24, and the
other GDP bound, which interacts with Bem1. Analysis of
mutant forms of Bud1 indicates that the in vitro binding is
functionally significant in vivo.
Our findings demonstrate the coupling of two GTPase
cycles in the process of determining cell polarity: Bud1 directly
associates with Cdc24, a guanine nucleotide exchange protein
for Cdc42. In vivo studies with mammalian cells have led to the
proposal that a GTPase cascade involving the ordered function
of Cdc42, Rac, and Rho proteins governs cytoskeletal orga-
nization (38). The GTPase cascade that we describe functions
upstream of a possible cascade involving Cdc42 and the other
yeast Rho proteins (39).
We previously proposed that association of Bud1 with other
proteins necessary for cell polarity guides these proteins to a
proper cellular site (13). Having established that Bud1 does
indeed interact with this class of proteins, we propose a
possible sequence of events in which Bud1 guides a macro-
molecular assembly process in which hydrolysis of GTP pro-
vides a monitor of progress through the different steps.
Association of Bud1–GTP with Cdc24. We have used two
different methods to show that Bud1 associates with Cdc24 in
a GTP-dependent manner in vitro. In one case, we recovered
proteins bound to a GST–Bud1 fusion protein containing all
272 residues of Bud1. In the second case, we recovered
proteins associated with an MBP–Cdc24 fusion protein. Both
analyses demonstrated that Bud1–GTP preferentially associ-
ated with Cdc24. Zheng et al. (17) also demonstrated binding
of Cdc24 to GTP-bound Bud1 in vitro by using full-length Bud1
and Cdc24 proteins.
Our studies provide further information on the regions of
Cdc24 and Bud1 that are important for this interaction.
Because the MBP–Cdc24 fusion protein contains only the
C-terminal half of Cdc24 (residues 472–854), it is apparent that
this part of the protein, which lacks the catalytic domain (28),
FIG. 4. Subcellular fractionation and solubilization of Bud1 from
the particulate fraction. (A) Subcellular fractionation and solubiliza-
tion of wild-type Bud1. Cells of yeast strain expressing HA-epitope-
tagged Bud1 were broken open by bead beating and centrifuged at
500 3 g to produce whole cell extract (wce); the wce was subsequently
centrifuged at 10,000 3 g to produce pellect (P) and supernatant (S)
fractions (lanes 1 and 2). Aliquots of the pellet fractions (P) were
washed with the same lysis buffer (lanes 3 and 4) or treated with 500
mM NaCl (lanes 5 and 6), 2% Triton (lanes 7 and 8), and 1% SDS
(lanes 9 and 10) before centrifuging at 10,000 3 g again (34). Both
pellet and supernatant fractions from equal amounts of cells (OD600
unit) were loaded on 10% polyacrylamide gel and subjected to
immunoblot analysis using monoclonal antibodies against HA epitope
to detect HA-tagged Bud1. As a control for fractionation, identical
samples were also subjected to immunoblot analysis using antibodies
against the yeast endoplasmic reticulummembrane protein Sec61 (36).
(B) Subcellular fractionation of Bud1G12V and Bud1K16N. Cells of
yeast strain expressing HA-epitope-tagged Bud1G12V or Bud1K16N
were treated in the same way as described in A.
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is sufficient for interaction with Bud1. A further indication of
the residues that are important for binding of Cdc24 to Bud1
comes from analysis of the Bud1T35Amutant. This mutant form
of Bud1 was designed to test the idea that Bud1 interacts with
an effector such as Cdc24 in the same manner as H-ras with its
effector, raf. The residue Thr-35 is necessary for binding of
H-ras to raf (32) and is also required for binding of Bud1 to
Cdc24. We furthermore observed that this mutant form of
Bud1 does not provide Bud1 function in vivo: the bud1T35A
mutant exhibits a random budding pattern and is unable to
suppress the growth defect of a cdc24ts mutant at nonper-
missive temperature. Similar in vivo observations were recently
reported by Michelitch and Chant (41). These observations
indicate that Thr-35 is part of the effector region of Bud1,
necessary for interaction with Cdc24.
Association of Bud1–GDPwith Bem1. In contrast to binding of
Cdc24, Bem1 binds preferentially to the GDP-bound form of
Bud1. In addition, it binds equally well to the Bud1T35A protein
when this mutant protein is bound to GTP[gS] or to GDP. The
ability of Bud1T35A to interact with Bem1 indicates that Bud1T35A
is not grossly misfolded and instead suggests that it may be locked
into a conformation like that of theGDP-bound state. In contrast
to the situation for binding of Bud1 and Cdc24, we cannot yet
evaluate the physiological significance of the in vitro binding of
Bud1 and Bem1: we will need to search for mutants of Bud1 or
Bem1 that specifically affect their interaction in vitro and then
examine their phenotype in vivo. Despite this gap in our knowl-
edge, we consider the binding of Bud1–GDP to Bem1 to be
striking and thought-provoking. Below we propose that their
association plays a crucial role in a series ofmorphogenetic events
leading to actin organization.
The Bem1 protein has a wealth of binding partners. In
particular, it has recently been shown to associate with Ste20,
Cdc24, Far1, and actin (17, 28, 42, 43). Binding of Bem1 and
Cdc24 has been demonstrated in vivo by the two-hybrid system
(28) and in vitro, in which case binding is sensitive to Ca21 (17).
The fission yeast homologues of Cdc24 and Bem1 (Scd1 and
Scd2, respectively) have also been shown to associate with each
other in vitro (40).
It has been generally accepted that the GTP-bound state of
GTPases such as ras is the active form. This is clearly the case
for oncogenic forms of ras (for review, see ref. 44) and for
other activated forms of ras (45–47). Our observations indicate
that Bud1 also has a second active form, the GDP-bound form.
We stress that this interaction between the GDP-bound form
of Bud1 and Bem1 is novel. Proteins that bind to GDP-bound
forms of GTPases are known, but there is no reason to think
that Bem1 is either a guanine nucleotide exchange protein or
a guanine nucleotide dissociation inhibitor (GDI). GDI pro-
teins interact with prenylated membrane-bound forms of
GTPases (48), but Bem1 interacts in vitro with unprenylated
Bud1 protein synthesized in E. coli. Another example of the
GDP-bound form of a GTPase having a binding partner
distinct from an exchange protein or GDI has recently been
described for the Ran protein, which is involved in uptake of
proteins into the nucleus (49). The examples of Ran and Bud1
make it clear that GTPases such as Ras and Rho family
members have two active forms and should not be viewed
exclusively as an ONyOFF switch in which only the GTP-
bound form is functional.
A Scheme for Bud-Site Assembly.We had earlier proposed
that the Bud1 GTPase cycle is involved in localizing proteins
necessary for cell polarity to a cellular landmark (13). The
finding that mutants defective in the GTPase itself (Bud1)
exhibit the same phenotype as mutants defective in the
GTPase-activating protein (Bud2) or in the guanine nucle-
otide exchange factor (Bud5) led to the proposal that Bud1
must cycle between GTP- and GDP-bound forms to function
(13). Based on in vitro binding and subcellular fractionation
data for Bud1, we now propose a scheme by which these
proteins interact with each other and with the bud-site
landmark to establish a position for polarization of the actin
cytoskeleton (Fig. 5). We have incorporated the following
new information into this scheme: Bud1–GTP binds to
Cdc24 (this paper and ref. 17), Bud1–GDP binds to Bem1
(this paper), and Cdc24 binds to Bem1 (17, 28).
The end result of the bud-site selection process is the
localization of Bem1 and the active species of Cdc42 (Cdc42-
GTP) at a specific cellular location. These proteins are known
to be localized at the nascent budding site (30, 37). We propose
that in step 1 (Fig. 5), association of Bud1–GTP and its binding
partners would yield a complex of Bud1–GTP, Cdc24, Cdc42-
GDP, and Bem1 at the cellular landmark that defines the bud
site (7). Bem1 might join the complex through its association
with Cdc24. Cdc42–GDP might join the complex through its
association with its guanine nucleotide exchange factor, Cdc24
(24), or through the direct interaction with Bud1–GTP (H.-
O.P., unpublished results). In step 2, several critical events
could occur in a coupled process that leads to activation of
Cdc42. In one scenario, Bud1–GTP is converted to Bud1–GDP
through action of its GTPase-activating protein, Bud2 (which
is localized to the bud site; H.-O.P., unpublished results).
Bud1, now in its GDP-bound state, no longer associates with
Cdc24 and instead becomes a binding partner for Bem1.
Dissociation of Bem1 from Cdc24 may allow Cdc24 to become
active and, therefore, convert Cdc42–GDP to Cdc42–GTP.
Conversion of Bud1–GDP to Bud1–GTP by Bud5 in step 3
would allow recycling of Bud1 and further shuttling of Cdc24,
Cdc42, and Bem1 to the bud site. The cycle is thus proposed
to result in localization of a critical level of Cdc42–GTP and
Bem1 proteins to the bud site, which then organizes the
cytoskeleton through unknown mechanisms.
Our subcellular fractionation data on Bud1 suggest that
some Bud1–GTP is soluble before it forms a complex at the
bud site whereas Bud1–GDP is always associated with the
FIG. 5. Scheme for function of a GTPase cascade in determination
of yeast cell polarity. In this model, the GTPase Bud1 determines the
localization to the bud site of proteins that organize the actin cy-
toskeleton—Bem1, Cdc24, and the GTPase Cdc42. First, a tetrapartite
complex is formed at the bud site, at which the Bud2, the GTPase-
activating protein for Bud1, appears to be located (H.-O.P., unpub-
lished results). Bud2 stimulates conversion of Bud1–GTP to Bud1–
GDP, which allows a reconfiguration of components at the bud site and
activation of Cdc24. This guanine nucleotide exchange factor, Cdc24,
then stimulates formation of Cdc42–GTP, which is presumably the
active species for organizing the actin cytoskeleton. Bud1–GDP is
converted to Bud1–GTP by its guanine-nucleotide exchange factor,
Bud5. Multiple rounds of this cycle may result in a critical concen-
tration of Bem1 and Cdc42–GTP at the presumptive bud site, which
stimulates polarization of the actin cytoskeleton toward that point (see
text for details).
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plasma membrane. These observations are consistent with the
view that Bud1 shuttles between the bud site on the plasma
membrane and the cytosol to bring proteins essential for bud
formation to the proper bud site. Michelitch and Chant (41)
recently reported that Bud1 is present only in the pellet
fraction, which differs from our observation. It is possible that
the HA antibody that we used is more sensitive than the
polyclonal antibody used by Michelitch and Chant (41).
Recent studies with fission yeast (40) and mammalian cells
(38) show that Ras proteins control not only signal transduc-
tion pathways but also morphogenesis. In fission yeast, two-
hybrid analysis and in vitro experiments indicate the existence
of interactions between Ras and homologues of Cdc24, Cdc42,
and Bem1 that are involved in morphogenesis. As noted by
Chang et al. (40), the Bud1 protein of budding yeast can be
viewed as a specialized form of Ras that is exclusively dedi-
cated to morphogenesis. In fission yeast and in mammalian
systems, the same Ras protein functions in both signal trans-
duction and morphogenesis. Despite this difference between
budding yeast and these other organisms, Ras-like proteins
and their binding partners are conserved. Thus the mechanism
by which Bud1 functions in organizing the actin cytoskeleton
may also be conserved.
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